Cromolyn Sodium Articles
Rx-to-OTC switching making comeback
21 April 2008
Azur Pharma completes $48M financing and FazaClo buy
13 August 2007
Manhattan acquires drug candidates
16 April 2007
King and Inyx enter strategic alliance
19 September 2005
King's Intal HFA on track for US approval
10 November 2003
King buys Aventis drug rights for $200M
6 January 2003
IVAX buys intranasals from Roche
1 April 2002
Product News In Brief
25 June 1998
Product Swap By J&J And P&U
11 June 1997
McNeil's Nasalcrom Cleared For OTC Sales
13 January 1997
McNeil's Nasalcrom Approved In USA
21 October 1996
Fisons Launches Gastrocrom For Mastocytosis
29 April 1996
Phase III Results With Zeneca's Accolate
13 March 1995
Bausch & Lomb Deal
27 February 1995
US FDA Cttees View epinephrine, Ephedrine
5 December 1994
AAFA Cites Cromolyn Misuse Potential
24 October 1994
OTC Switches in the USA
18 July 1994
US FDA APPROVES NEW GENERICS
16 May 1994
FISONS AND ALLERGAN LINK-UP
8 February 1993
Showing 1-20 of 20 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
